Search Results - "Prostate cancer"

Multiple metastases of androgen indifferent prostate cancer in the urinary tract: two case reports and a literature review by Tsukasa Masuda, Takeo Kosaka, Kohei Nakamura, Hiroshi Hongo, Kazuyuki Yuge, Hiroshi Nishihara, Mototsugu Oya

Connect to this object online.

Combination of the PARPi and ARSi in advanced castration resistant prostate cancer: a review of the recent phase III trials by Martina Panebianco, Vittore Cereda, Mario Rosario D'Andrea

Connect to this object online.

Hidden intra-mandibular carcinoma cuniculatum appearing in a patient with metastatic prostate cancer: a case report by Elyette Broly, Philippe Barthélémy, Saïd Ciftci, Christian Borel, Martin Broly, Catherine-Isabelle Gros, Luc Marcellin, Fabien Bornert

Connect to this object online.

Diagnostic utility of α-methylacyl CoA racemase (P504S) & HMWCK in morphologically difficult prostate cancer by Singh Shrawan, Mandal Arup, Verma Alka, Kakkar Nandita, Kumaresan K, Joshi Kusum

Connect to this object online.

Seed-mediated RNA interference of androgen signaling and survival networks induces cell death in prostate cancer cells by Joshua M. Corbin, Constantin Georgescu, Jonathan D. Wren, Chao Xu, Adam S. Asch, Maria J. Ruiz-Echevarría

Connect to this object online.

Liquid biopsy‐based targeted gene screening highlights tumor cell subtypes in patients with advanced prostate cancer by Seta Derderian, Quentin Vesval, Michel D. Wissing, Lucie Hamel, Nathalie Côté, Marie Vanhuyse, Cristiano Ferrario, Franck Bladou, Armen Aprikian, Simone Chevalier

Connect to this object online.

Enzyme-Enhanced Codelivery of Doxorubicin and Bcl-2 Inhibitor by Electrospun Nanofibers for Synergistic Inhibition of Prostate Cancer Recurrence by Zheng Liu, Xing Luo, Yongxin Mo, Pengkai Zhao, Haixia Wang, Youqiang Fang, Yanteng Xu

Connect to this object online.

Treatment-Emergent Co-Morbidities and Survival in Patients With Metastatic Castration-Resistant Prostate Cancer Receiving Abiraterone or Enzalutamide by Yi-Ting Lin, Yi-Ting Lin, Yi-Ting Lin, Yen-Chun Huang, Yen-Chun Huang, Chih-Kuan Liu, Chih-Kuan Liu, Tian-Shyug Lee, Tian-Shyug Lee, Mingchih Chen, Mingchih Chen, Yu-Ning Chien, Yu-Ning Chien

Connect to this object online.

Barriers and facilitators of the implementation of the application of pelvic floor muscle training in patients with prostate cancer: a scoping review by Lijuan Wang, Yaqin Li, Ziyi Qi, Wei Wang

Connect to this object online.

Validation of a prognostic blood-based sphingolipid panel for men with localized prostate cancer followed on active surveillance by Justin R. Gregg, Lisa Newcomb, Ranran Wu, Jennifer Dennison, John W. Davis, Curtis Pettaway, Louis Pisters, John F. Ward, Brian F. Chapin, Lisly Chéry, Ahmet Urkmez, Andrew M. Fang, Noel Higgason, Patricia Troncoso, Carrie R. Daniel, Christopher Logothetis, Timothy C. Thompson, Andrew W. Hahn, Menghan Liu, Yingye Zheng, Dan W. Lin, Samir Hanash, Ehsan Irajizad, Johannes Fahrmann

Connect to this object online.

Whole slide imaging (WSI) scanner differences influence optical and computed properties of digitized prostate cancer histology by Savannah R. Duenweg, Samuel A. Bobholz, Allison K. Lowman, Margaret A. Stebbins, Aleksandra Winiarz, Biprojit Nath, Fitzgerald Kyereme, Kenneth A. Iczkowski, Peter S. LaViolette

Connect to this object online.

Optimized ⁶⁸Ga-Labeled Urea-Based PSMA-Targeted PET Tracers for Prostate Cancer by Yitian Wu, Xiaojun Zhang, Ying Zhang, Baixuan Xu, Jiahe Tian, Jinming Zhang

Connect to this object online.

Bisphenol-A exposure and risk of breast and prostate cancer in the Spanish European Prospective Investigation into Cancer and Nutrition study by Elena Salamanca-Fernández, Miguel Rodríguez-Barranco, Pilar Amiano, Josu Delfrade, Maria Dolores Chirlaque, Sandra Colorado, Marcela Guevara, Ana Jimenez, Juan Pedro Arrebola, Fernando Vela, Nicolás Olea, Antonio Agudo, Maria-José Sánchez

Connect to this object online.

Alpha emitter radium-223 in patients with metastatic castration-resistant prostate cancer: A cost-utility analysis by Xiaohui Zeng, Qiao Liu, Chongqing Tan, Xiaomin Wan, Yunhua Wang, Xiaowei Ma

Connect to this object online.

The Positive Correlations between the Expression of Histopathological Ubiquitin-Conjugating Enzyme 2O Staining and Prostate Cancer Advancement by Jae-Heon Kim, Hee-Jo Yang, Chang-Ho Lee, Youn-Soo Jeon, Jae-Joon Park, Kwang-Woo Lee, Jae-Ho Kim, Su-Yeon Park, Su-Jung Song, Yon-Hee Kim, Ah-Rim Moon, Ji-Hye Lee, Yun-Seob Song

Connect to this object online.

Geographic and socioeconomic variation in treatment of elderly prostate cancer patients in Norway - a national register-based study by Elin Marthinussen Gustavsen, Erik Skaaheim Haug, Ellinor Haukland, Ragnhild Heimdal, Eva Stensland, Tor Åge Myklebust, Beate Hauglann

Connect to this object online.

Adding Enzalutamide to First-Line Treatment for Metastatic Hormone-Sensitive Prostate Cancer: A Cost-Effectiveness Analysis by Peng-Fei Zhang, Peng-Fei Zhang, Dan Xie, Dan Xie, Qiu Li, Qiu Li

Connect to this object online.

Rare histologic transformation of a CTNNB1 (β-catenin) mutated prostate cancer with aggressive clinical course by Dilara Akhoundova, Stefanie Fischer, Joanna Triscott, Marika Lehner, Phillip Thienger, Sina Maletti, Muriel Jacquet, Dinda S.H. Lubis, Lukas Bubendorf, Wolfram Jochum, Mark A. Rubin

Connect to this object online.

Piperlongumine inhibits migration and proliferation of castration-resistant prostate cancer cells via triggering persistent DNA damage by Ding-fang Zhang, Zhi-chun Yang, Jian-qiang Chen, Xiang-xiang Jin, Yin-da Qiu, Xiao-jing Chen, Hong-yi Shi, Zhi-guo Liu, Min-shan Wang, Guang Liang, Xiao-hui Zheng

Connect to this object online.

Chloroacetanilide use and prostate cancer risk among agricultural French pesticide users in the AGRiculture and CANcer (AGRICAN) cohort. by Juliette Hippert, Marine Renier, Mathilde Boulanger, Anne-Valérie Guizard, AGRICAN GROUP, Elisabeth Marcotullio, Isabelle Baldi, Pierre Lebailly

Connect to this object online.